ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2011

ACR Criteria, Providers’ Global Rating of Change and Role of Patient Self-Report in Evaluating Change in Disease Over Time: A Patient Reported Outcomes Measurement Information System Study

Bin Huang1, Jennifer Farrell2, Adam Carle3, Stacey Niehaus3, Hermine Brunner4, Alexei A. Grom5, Michael Henrickson6, Jennifer L. Huggins4, D. J. Lovell7, Tracy V. Ting4 and Esi M. Morgan DeWitt2, 1Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center/University of Cincinnati School of Medicine, Cincinnati, OH, 2Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5PRCSG, Cincinnati, OH, 6MLC 4010, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 7Cincinnati Children's Hospital, Cincinnati, OH

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: juvenile idiopathic arthritis (JIA), longitudinal studies and outcome measures

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose:

As part of a longitudinal study of Juvenile Idiopathic Arthritis (JIA), providers completed clinical outcomes assessments and patients (pt) completed self-report measures at clinic visits.  In addition to measuring ACR Pediatric response based on the 6 core variables (CHAQ, active joint count, loss of motion, ESR, physician global assessment (PGA), and pt’s well-being), providers rated the pt’s global change of overall health (GRC-health) and JIA (GRC-JIA) between visits on a scale from 1 (very much worse) to 7 (very much better).  Pt’s report of pain and health-related quality of life (HRQoL) are not part of the core measures.  Study Aims: 1) To assess the relationship between JIA improvement at the ACR-Ped70 level with the provider’s GRC-health and GRC-JIA ratings; 2) To evaluate whether pain and HRQoL as assessed by the PedsQL Core and Rheumatology modules are associated with the  provider’s GRC-health and GRC-JIA ratings.

Methods:

Inclusion criteria were diagnosis of JIA, age 8-18 yrs at enrollment, and English fluency.  Study visits occurred 3-4 times/yr concomitantly with scheduled clinic visits.  Analyses considered baseline data and 2nd assessments.

Results:

Data on 113 JIA pts was available (mean age=13.1±2.7 yrs; range=8.1-18.4 yrs).  Majority (86) were female (71%); 72 had polyarthritis (63.7%), 18 oligoarthritis (16%), 11 systemic JIA (9.7%) and 12 other (10.6%).  Mean age at diagnosis was 9.0±4.4 yrs.  The GRC-health (N=95) and the GRC-JIA (N=106) were highly correlated (r = 0.73, P <.0001).  At 2nd assessment, 10.6% (n=12) achieved an ACR-Ped70 treatment response from baseline. ACR-Ped70, 50 and 30 improvements were all moderately correlated with GRC ratings (r range: .32-.43, P<.001).  ACR-Ped70 responders significantly differed from others in their GRC-health (4.1±1.2 vs. 5.8±1.1; P<.001) and GRC-JIA ratings (4.4±1.1 vs. 6.3±0.97; P <.001). All ACR-Ped70 responders had GRC-health and GRC-JIA ratings >4.  Both GRC ratings were significantly (P<.05) correlated with ACR core measures except ESR (P<.12) (r range: .18 -.46), and with pt’s pain (r = 0.4, .45; P<.0001).  PedsQL Core and Rheumatology Module total and domain scores were significantly correlated with both GRC ratings and ACR-Ped response levels.  The final GRC-health multivariable model included ACR-Ped70, gender, ACR-Ped70 by gender interaction, JIA subtype, active joint count and pt’s pain; none of the PedsQL scores remained significant.  Age was not significant. The final GRC-JIA model includes PGA as a significant predictor, in addition to those included in the GRC-health model.

Conclusion:

Provider’s ratings of overall health and JIA change are closely related to the level of improvement as measured by the ACR-Ped Criteria. Provider’s GRC are significantly influenced by patient’s pain rating, and takes account of the active joint count over and beyond the ACR-Ped70 response level. Nonetheless, in comparison to the ACR-JIA Response Criteria the provider’s GRC can serve as a valid measure to assess patient’s change over time, but with differential gender effect.  This study also suggests that patient reported pain should be considered in the assessment of disease progression.


Disclosure:

B. Huang,
None;

J. Farrell,
None;

A. Carle,
None;

S. Niehaus,
None;

H. Brunner,
None;

A. A. Grom,

Novartis Pharmaceutical Corporation,

5,

Roche Pharmaceuticals,

5,

NovImmune,

5;

M. Henrickson,
None;

J. L. Huggins,
None;

D. J. Lovell,
None;

T. V. Ting,
None;

E. M. Morgan DeWitt,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/acr-criteria-providers-global-rating-of-change-and-role-of-patient-self-report-in-evaluating-change-in-disease-over-time-a-patient-reported-outcomes-measurement-information-system-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology